| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes New Fortress Energy Inc. (NYSE:NFE), but "right now Wes Edens [co-founder of Fortress Investment Group and founder of New Fortress Energy] is kind of just hurt by the president.”
On March 5, New Fortress Energy reported upsizing and pricing of $750 million of senior secured notes.
Cramer said he likes Cummins Inc. (NYSE:CMI) and recommended buying the stock. "I think it’s terrific," he added.
On March 14, Truist Securities analyst Jamie Cook initiated coverage on the shares of Cummins with a Hold rating and a price target of $303.
When asked about Palantir Technologies Inc. (NYSE:PLTR), Cramer said, "Make a move and buy some."
The company, last week, inked a pact with Oracle to provide secure cloud and AI solutions to power businesses and governments worldwide.
The "Mad Money" host recommended buying The PNC Financial Services Group, Inc. (NYSE:PNC). "You got horse sense," he added.
On April 8, Jefferies analyst Ken Usdin maintained PNC Finl with a Hold and raised the price target from $164 to $171.
"I really want" you in Abbott Laboratories (NYSE:ABT), Cramer said.
The FDA, last week, approved Abbott Laboratories’ first-of-its-kind TriClip transcatheter edge-to-edge repair (TEER) system that’s specifically designed to treat tricuspid regurgitation (TR), or a leaky tricuspid valve.
Cramer recommended selling NIO Inc. (NYSE:NIO).
On April 9, NIO filed its 2023 annual report on Form 20-F.
Read Next: Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter
